![](/img/cover-not-exists.png)
Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5
Huang, Feng, Sun, Fei, Wan, Wei-Guo, Wu, Li-Jun, Dong, Ling-Li, Zhang, Xiao, Kim, Tae-Hwan, Sengupta, Raj, Å enolt, Ladislav, Wang, Yi, Qiu, Hao-Min, Porter, Brian, Haemmerle, SibylleVolume:
133
Journal:
Chinese Medical Journal
DOI:
10.1097/cm9.0000000000001099
Date:
November, 2020
File:
PDF, 660 KB
2020